SEC Form 5 · accession 0000899243-19-002650
Jazz Pharmaceuticals plc · JAZZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rick E Winningham
Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 5, 2019 · 5:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 24, 2018 | G | 1,720 | $0.00 | D | 3,230 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents ordinary shares that the Reporting Person donated as a gift to the Fidelity Investment Charitable Gift Fund, a donor advised fund.